Cytotoxicity of drugs injected into joints in orthopaedics

Abstract

Objectives Intra-articular injections of local anaesthetics (LA), glucocorticoids (GC), or hyaluronic acid (HA) are used to treat osteoarthritis (OA). Contrast agents (CA) are needed to prove successful intra-articular injection or aspiration, or to visualize articular structures dynamically during fluoroscopy. Tranexamic acid (TA) is used to control haemostasis and prevent excessive intra-articular bleeding. Despite their common usage, little is known about the cytotoxicity of common drugs injected into joints. Thus, the aim of our study was to investigate the effects of LA, GC, HA, CA, and TA on the viability of primary human chondrocytes and tenocytes in vitro . Methods Human chondrocytes and tenocytes were cultured in a medium with three different drug dilutions (1:2; 1:10; 1:100). The following drugs were used to investigate cytotoxicity: lidocaine hydrochloride 1%; bupivacaine 0.5%; triamcinolone acetonide; dexamethasone 21-palmitate; TA; iodine contrast media; HA; and distilled water. Normal saline served as a control. After an incubation period of 24 hours, cell numbers and morphology were assessed. Results Using LA or GC, especially triamcinolone acetonide, a dilution of 1:100 resulted in only a moderate reduction of viability, while a dilution of 1:10 showed significantly fewer cell counts. TA and CA reduced viability significantly at a dilution of 1:2. Higher dilutions did not affect viability. Notably, HA showed no effects of cytotoxicity in all drug dilutions. Conclusion The toxicity of common intra-articular injectable drugs, assessed by cell viability, is mainly dependent on the dilution of the drug being tested. LA are particularly toxic, whereas HA did not affect cell viability. Cite this article : P. Busse, C. Vater, M. Stiehler, J. Nowotny, P. Kasten, H. Bretschneider, S. B. Goodman, M. Gelinsky, S. Zwingenberger. Cytotoxicity of drugs injected into joints in orthopaedics. Bone Joint Res 2019;8:41–48. DOI: 10.1302/2046-3758.82.BJR-2018-0099.R1.

Primary Human Chondrocytes Affected by Cigarette Smoke—Therapeutic Challenges

“…Our results indicated that clinical concentrations of Dex are toxic to chondrocytes, while lower concentrations (4-400 µg/mL) seem to be non-toxic, when no additional CSE is applied. These results are in agreement with the findings of Busse et al [51], showing that lower concentrations of Dex have less detrimental effects on chondrocytes compared to clinical concentrations. In addition, the work of Stewart and colleagues reported that treatment with Dex stimulated AP activity and AP mRNA of equine mesenchymal stem cells and might, therefore, induce the cells to differentiate toward bone [52].…”

Optimal concentration of ethylenediaminetetraacetic acid as an irrigation solution additive to reduce infection rates in rat models of contaminated wound

“… 8 The cytotoxicity of surfactants, bactericides, and antiseptics is usually considered to be responsible for their ineffectiveness in reducing infection rates. 6 - 10 …”

Optimal route for administering tranexamic acid in primary unilateral total hip arthroplasty: Results from a multicenter cohort study

“…This may reflect the fact that a single bolus of intravenous or topical TXA can maintain haemostasis for less than 24 hours because of the drug's limited half‐life in the body. This limitation is difficult to avoid in the case of topical application of TXA, as applying a high concentration (50 or 100 mg/mL) topically to ensure long contact time with tissue can cause significant toxicity to periarticular tissue . We believe that intravenous administration of TXA may be preferable to topical TXA because of its better antifibrinolytic effect.…”